Biosimilar Clinical Development: Scientific Considerations and New Methodologies

<p>Biosimilars have the potential to change the way we think about identify and manage health problems. They are already impacting both clinical research and patient care and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development this book discusses various potential drug development strategies the design and analysis of pharmacokinetics (PK) studies and the design and analysis of efficacy studies.</p>